WallStSmart

MKS Instruments Inc (MKSI)vsNovanta Inc (NOVT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 301% more annual revenue ($3.93B vs $980.60M). MKSI leads profitability with a 7.5% profit margin vs 5.5%. MKSI appears more attractively valued with a PEG of 1.32. MKSI earns a higher WallStSmart Score of 55/100 (C-).

MKSI

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.20

NOVT

Hold

44

out of 100

Grade: D

Growth: 4.7Profit: 5.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKSISignificantly Overvalued (-64.0%)

Margin of Safety

-64.0%

Fair Value

$158.01

Current Price

$243.68

$85.67 premium

UndervaluedFair: $158.01Overvalued
NOVTSignificantly Overvalued (-1143.0%)

Margin of Safety

-1143.0%

Fair Value

$11.41

Current Price

$117.65

$106.24 premium

UndervaluedFair: $11.41Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKSI0 strengths · Avg: 0/10

No standout strengths identified

NOVT0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MKSI4 concerns · Avg: 2.5/10
Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

P/E RatioValuation
55.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

NOVT4 concerns · Avg: 3.5/10
PEG RatioValuation
2.114/10

Expensive relative to growth rate

EPS GrowthGrowth
0.6%4/10

0.6% earnings growth

Return on EquityProfitability
5.2%3/10

ROE of 5.2% — below average capital efficiency

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MKSI

Revenue growth of 10.6% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : NOVT

NOVT has a balanced fundamental profile.

Bear Case : MKSI

The primary concerns for MKSI are Profit Margin, Debt/Equity, P/E Ratio. A P/E of 55.9x leaves little room for execution misses. Debt-to-equity of 1.76 is elevated, increasing financial risk.

Bear Case : NOVT

The primary concerns for NOVT are PEG Ratio, EPS Growth, Return on Equity. A P/E of 81.3x leaves little room for execution misses.

Key Dynamics to Monitor

MKSI carries more volatility with a beta of 1.92 — expect wider price swings.

MKSI is growing revenue faster at 10.6% — sustainability is the question.

MKSI generates stronger free cash flow (91M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKSI scores higher overall (55/100 vs 44/100) and 10.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Novanta Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.

Want to dig deeper into these stocks?